Allgenesis DRC A Multicenter, Prospective, Randomized, Double-masked Study Evaluating the Safety, Tolerability, and Efficacy of Topical AG-86893 in Patients with Pterygium
Research Grant
Administered By
Ophthalmology
Awarded By
Allgenesis Biotherapeutics
Start Date
June 12, 2018
End Date
July 31, 2020
Administered By
Ophthalmology
Awarded By
Allgenesis Biotherapeutics
Start Date
June 12, 2018
End Date
July 31, 2020